These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7784308)

  • 21. Protective effects of papaverine salicylate in mouse ear dermatitis and PAF-induced rat paw oedema.
    de Bernardis E; Leonardi G; Caruso A; Cutuli VM; Amico-Roxas M
    Agents Actions; 1994 Aug; 42(1-2):29-33. PubMed ID: 7847181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological modulation of 2-methyl-carbamate-PAF induced rat paw oedema.
    Castro-Faria-Neto HC; Silva PM; Martins MA; Silva PS; Henriques MG; Cordeiro RS; Vargaftig BB
    J Pharm Pharmacol; 1990 Mar; 42(3):203-4. PubMed ID: 1974620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Release of platelet activating factor and its involvement in the first phase of carrageenin-induced rat foot edema.
    Hwang SB; Lam MH; Li CL; Shen TY
    Eur J Pharmacol; 1986 Jan; 120(1):33-41. PubMed ID: 3948914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective role of propionyl carnitine in vascular disorders experimentally induced by endothelin (ET-1) serotonin and K-carrageenin.
    Bertelli A; Giovannini L; Galmozzi G; Bertelli AA
    Drugs Exp Clin Res; 1993; 19(1):7-11. PubMed ID: 8223141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The anti-inflammatory activity of structural analogs of the platelet-activating factor].
    Melikiants AG; Kulikov VI; Koloskova EE; Kuznetsova TI; Dergousov AA; Lipatkina LIu
    Farmakol Toksikol; 1991; 54(4):43-5. PubMed ID: 1786825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local activity of anti-inflammatory and irritant agents on rat paw edema induced by carrageenin.
    Shanahan RW
    Arch Int Pharmacodyn Ther; 1968 Sep; 175(1):186-92. PubMed ID: 5703243
    [No Abstract]   [Full Text] [Related]  

  • 27. Alterations in energy metabolism of hypertrophied rat cardiomyocytes: influence of propionyl-L-carnitine.
    Torielli L; Conti F; Cinato E; Ceppi E; Anversa P; Bianchi G; Ferrari P
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):372-80. PubMed ID: 8583777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of inflammatory paw oedema by cysteamine in the rat.
    Salam OM
    Pharmacol Res; 2002 Apr; 45(4):275-84. PubMed ID: 12030790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Desensitization to PAF-induced rat paw oedema by repeated intraplantar injections.
    Cordeiro RS; Martins MA; Silva PM; Faria Neto HC; Castanheira JR; Vargaftig BB
    Life Sci; 1986 Nov; 39(20):1871-8. PubMed ID: 3773645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual inhibition of platelet-activating factor and arachidonic acid metabolism by ajmaline and effect on carrageenan-induced rat paw oedema.
    Saeed SA; Simjee RU; Mahmood F; Rahman NN
    J Pharm Pharmacol; 1993 Aug; 45(8):715-9. PubMed ID: 7901369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The activity of suprofen on nystatin-induced paw oedema in rats.
    Niemegeers CJ; Awouters F; Lenaerts FM; Janssen PA
    Arzneimittelforschung; 1975 Oct; 25(10):1516-9. PubMed ID: 1243032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the crude extract of Cestrum parqui on carrageenin-induced rat paw oedema and aggregation of human blood platelets.
    Shehnaz D; Hamid F; Baqai FT; Uddin Ahmad V
    Phytother Res; 1999 Aug; 13(5):445-7. PubMed ID: 10441792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug modulation of antigen-induced paw oedema in guinea-pigs: effects of lipopolysaccharide, tumour necrosis factor and leucocyte depletion.
    da Motta JI; Cunha FQ; Vargaftig BB; Ferreira SH
    Br J Pharmacol; 1994 May; 112(1):111-6. PubMed ID: 8032630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions between local inflammatory and systemic haematological effects of PAF-acether in the rat.
    Martins MA; Silva PM; Castro HC; Neto F; Lima MC; Cordeiro RS; Vargaftig BB
    Eur J Pharmacol; 1987 Apr; 136(3):353-60. PubMed ID: 3609124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The propionyl-L-carnitine hypothesis: an alternative approach to treating heart failure.
    Ferrari R; De Giuli F
    J Card Fail; 1997 Sep; 3(3):217-24. PubMed ID: 9330130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test.
    Cirino G; Peers SH; Flower RJ; Browning JL; Pepinsky RB
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3428-32. PubMed ID: 2470103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An endothelin-3-related synthetic biotinylated pentapeptide as a novel inhibitor of platelet-activating factor.
    Sato A; Suzuki T; Oikawa K; Ohta R; Ebina K
    Eur J Pharmacol; 2013 Aug; 714(1-3):142-7. PubMed ID: 23792041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rat paw oedema modeling and NSAIDs: Timing of effects.
    Cong HH; Khaziakhmetova VN; Zigashina LE
    Int J Risk Saf Med; 2015; 27 Suppl 1():S76-7. PubMed ID: 26639722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the levels of l-carnitine, acetyl-l-carnitine and propionyl-l-carnitine are involved in perfluorooctanoic acid induced developmental cardiotoxicity in chicken embryo.
    Jiang Q; Wang C; Xue C; Xue L; Wang M; Li C; Deng Z; Wang Q
    Environ Toxicol Pharmacol; 2016 Dec; 48():116-124. PubMed ID: 27771504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of B1 receptor mediating des-Arg9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin.
    Campos MM; Souza GE; Calixto JB
    Br J Pharmacol; 1996 Mar; 117(5):793-8. PubMed ID: 8851492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.